Effects of a dairy protein (whey) hydrolysate on blood sugar, metabolic rate, gut and immune function after eating.

Not Applicable

Not yet recruiting

• Conditions: Postprandial hyperglycaemia; Diet-induced thermogenesis; Gut barrier function; Immune function; Metabolic and Endocrine - Normal metabolism and endocrine development and function; Inflammatory and Immune System - Normal development and function of the immune system

• Registration Number: ACTRN12623000106639
• Lead Sponsor: niversity of Auckland Research Office

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-31
• Last Update Posted: 6 February 2023

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Male and female
• Age between 18 and 60 years
• Body mass index (BMI) between 18-25 kg/m2
• Normal fasting plasma glucose (less than or equal to 5.5 mmol/L)
• Otherwise Healthy, according to self-report

Exclusion Criteria

• Fasting plasma glucose >5.6 mmol/L, or known Type 1 or type 2 diabetes mellitus
• Medications controlling glycaemia
• Current or history of significant disease including cardiovascular disease; pancreatic disease, or other digestive diseases including inflammatory bowel syndrome/disease, ulcerative colitis, Crohn's disease; cancer; plus associated medications including steroids and atypical antipsychotics
• Recent body weight loss/gain > 10 % within previous 3 months or taking part in an active diet program; or current medications for weight loss; or intending to alter physical activity during study period.
• Previous bariatric surgery
• Current illness (including gastrointestinal or eating disorders)
• Taking any medication which might impact metabolic rate during the last 3 months
• Smoker or vaper, current or in previous 6 months
• Recreational drug user, current or in previous 6 months
• Pregnant or breastfeeding women, current or in previous 6 months
• Blood donation within previous 3 months
• Dislike or unwilling to consume test products, or hypersensitivities or allergies to these foods
• Unwilling/unable to comply with study protocol
• Participation in other clinical intervention studies, current or in previous 6 months
• Low iron status
• Considered unsuitable to participate by the PI

Study & Design

• Study Type: Interventional
• Study Design: Not specified